Facebook
Twitter
LinkedIn
ForwardPatient Guided Radiotherapy: Tools to Help Providers Support Patients when the "Right Choice" Isn't Always Clear (PRO 05)
When patients are frail, older, have comorbidities or have a poor performance status, providing recommendations about the most appropriate radiotherapy regimen (or hospice) can be complicated. When is a long-course of radiotherapy most appropriate? Short-course palliative radiotherapy? SBRT? Hospice care without radiotherapy? This activity gives providers concrete tools to take back to clinic with a framework for thinking about shared decision making with patients/families.
1. Determining intent of radiotherapy: When are we in radical/curative mode? Purely palliative mode? Disease modifying mode (i.e., to alter disease course without cure)?
2. Patient centered conversations about goals: how to discuss what is important to tailor radiotherapy to the individual?
3. Case studies to explore these tools.
Target Audience
This activity is designed to meet the interests of radiation oncologists, nurses, radiation therapists and residents.
Learning Objectives
Upon completion of this activity, participants should be able to do the following:
- Describe three different intentions of radiotherapy: curative, disease-modifying and palliative radiotherapy.
- List the essential components of having time-sensitive, meaningful conversations with patients and families about goals and values that can influence radiotherapy decision making.
- Joshua A. Jones, MD, is employed by University of Pennsylvania.
- Emily J. Martin, MD, is employed by University of California, Los Angeles.
All relevant financial relationships have been mitigated.
The person(s) above served as the developer(s) of this activity. Additionally, the Annual Meeting Steering Committee had control over the content of this activity.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
Available Credit
- 1.25 AMA PRA Category 1 Credit™The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.